These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8517448)

  • 1. Idarubicin hydrochloride turbidity versus incompatibility.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1993 Jun; 50(6):1134, 1137. PubMed ID: 8517448
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injection.
    Turowski RC; Durthaler JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2181-4. PubMed ID: 1781476
    [No Abstract]   [Full Text] [Related]  

  • 3. Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1993 Nov; 50(11):2359-63. PubMed ID: 8266963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incompatibility between ceftriaxone sodium and labetalol hydrochloride.
    Leader WG; Jones JM
    Am J Health Syst Pharm; 1996 Nov; 53(21):2639. PubMed ID: 8913397
    [No Abstract]   [Full Text] [Related]  

  • 6. Visual compatibility of injectable drugs used in the intensive care unit.
    Chiu MF; Schwartz ML
    Am J Health Syst Pharm; 1997 Jan; 54(1):64-5. PubMed ID: 9117793
    [No Abstract]   [Full Text] [Related]  

  • 7. Liposomal formulation of idarubicin.
    Slifirski P; Szelejewski W; Grynkiewicz G; Gubernator J; Kozubek A
    Acta Pol Pharm; 2003; 60(2):138-40. PubMed ID: 13678324
    [No Abstract]   [Full Text] [Related]  

  • 8. Solution structure of iron(III)-anthracycline complexes.
    Fiallo MM; Drechsel H; Garnier-Suillerot A; Matzanke BF; Kozlowski H
    J Med Chem; 1999 Jul; 42(15):2844-51. PubMed ID: 10425093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility and uncertainty of wastewater turbidity measurements.
    Joannis C; Ruban G; Gromaire MC; Chebbo G; Bertrand-Krajewski JL; Joannis C; Ruban G
    Water Sci Technol; 2008; 57(10):1667-73. PubMed ID: 18520026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of doxorubicin, daunorubicin, and idarubicin by capillary electrophoresis with laser-induced fluorescence detection.
    Pérez-Ruiz T; Martínez-Lozano C; Sanz A; Bravo E
    Electrophoresis; 2001 Jan; 22(1):134-8. PubMed ID: 11197162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mixtures of infusion solutions and drugs. Compatibility and incompatibility].
    Pecar A; Dirks B
    Anaesthesist; 1995 Nov; 44(11):793-803. PubMed ID: 8678272
    [No Abstract]   [Full Text] [Related]  

  • 12. A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia. AML Collaborative Group.
    Br J Haematol; 1998 Oct; 103(1):100-9. PubMed ID: 9792296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of topoisomerase inhibitors daunorubicin, idarubicin, and aclarubicin in the Drosophila Somatic Mutation and Recombination Test.
    Lehmann M; Vilar Kde S; Franco A; Reguly ML; Rodrigues de Andrade HH
    Environ Mol Mutagen; 2004; 43(4):250-7. PubMed ID: 15141364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nafcillin sodium incompatibility with acidic solutions.
    Jeglum EL; Winter E; Kotos M
    Am J Hosp Pharm; 1981 Apr; 38(4):462, 463. PubMed ID: 7282668
    [No Abstract]   [Full Text] [Related]  

  • 15. Turbidity as a probe of tubulin polymerization kinetics: a theoretical and experimental re-examination.
    Hall D; Minton AP
    Anal Biochem; 2005 Oct; 345(2):198-213. PubMed ID: 16129407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonodisruption of re-assembled casein micelles at different pH values.
    Madadlou A; Mousavi ME; Emam-djomeh Z; Ehsani M; Sheehan D
    Ultrason Sonochem; 2009 Jun; 16(5):644-8. PubMed ID: 19237307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flory temperature and upper critical solution temperature of gelatin solutions.
    Gupta A; Mohanty B; Bohidar HB
    Biomacromolecules; 2005; 6(3):1623-7. PubMed ID: 15877386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiometric/turbidometric titration of antiperspirant actives.
    Johnston CT; Hem SL; Guenin E; Mattai J; Afflito J
    J Cosmet Sci; 2003; 54(2):113-8. PubMed ID: 12715089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Net charge affects morphology and visual properties of ovalbumin aggregates.
    Weijers M; Broersen K; Barneveld PA; Cohen Stuart MA; Hamer RJ; De Jongh HH; Visschers RW
    Biomacromolecules; 2008 Nov; 9(11):3165-72. PubMed ID: 18844431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time turbidimetry of LAMP reaction for quantifying template DNA.
    Mori Y; Kitao M; Tomita N; Notomi T
    J Biochem Biophys Methods; 2004 May; 59(2):145-57. PubMed ID: 15163526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.